Portal: Breast Cancer
Search Results for Portal: Breast Cancer page 1
Relevance: Medium-High
Most relevant for: People who have an inherited mutation in BRCA1 or BRCA2 and have been diagnosed with TNBC
Study: BRCA mutations may improve pembrolizumab response in early TNBC
The BRCAPATH study looked at people with early-stage triple-negative breast cancer (TNBC). Participants received chemotherapy alone or chemotherapy plus the immunotherapy drug Keytruda (pembrolizumab) before surgery. People with a BRCA mutation, particularly those with a BRCA1 mutation, were more likely to have no sign of invasive cancer at the time of surgery than participants without a mutation. The results suggest that among people with early-stage TNBC, those with BRCA mutations are likely to respond well to this treatment. (posted 09/11/2026)
READ MORE ›
Relevance: Medium-High
Most relevant for: People who have or are considering breast implants
Update: What people with breast implants should know about rare cancers and other safety concerns
Breast implants are used for reconstruction after mastectomy and for cosmetic enlargement of the breasts. Most people with implants do not develop serious problems. However, rare cancers may develop in the scar tissue around breast implants. Implants may also be linked to other symptoms throughout the body, sometimes called breast implant illness. (posted 8/20/2026)
READ MORE ›
Relevance: Medium
Most relevant for: People taking or considering GLP-1 drugs
Study: GLP-1 drugs and breast cancer: results from ASCO 2026
Studies presented at the 2026 ASCO Annual Meeting looked at GLP-1 drugs in relation to breast cancer prevention and survival. Across these early studies, people taking GLP-1s drugs often had better breast cancer outcomes than similar people not taking them. (posted 7/20/2026)
READ MORE ›
Relevance: High
Most relevant for: • Black women diagnosed with invasive breast cancer at age 50 or younger
Study: Understanding inherited breast cancer risk in young Black women
This study looked at genetic testing for Black women diagnosed with breast cancer at age 50 or younger. The study found that about 15% of young Black women had an inherited mutation in a known breast cancer gene, most commonly BRCA1, BRCA2, or PALB2. These findings highlight the importance of genetic counseling and testing in guiding treatment and family risk assessment. (posted 7/13/2026)
READ MORE ›
Relevance: Medium-High
Most relevant for: People with breast cancer
Update: Approval of new breast cancer drugs increases treatment options
The FDA recently approved several new breast cancer treatments. Patients and doctors now have more treatment options for advanced and early-stage breast cancer. These treatments highlight the role of biomarker testing in guiding treatment decisions. (posted 6/22/2026)
READ MORE ›
Relevance: High
Most relevant for: cancer survivors experiencing ongoing anxiety after completing treatment who are looking for accessible, effective mental health support options.
Study: Music therapy as effective as cognitive behavioral therapy for anxiety in cancer survivors
A study published in the Journal of Clinical Oncology found that music therapy delivered by telehealth worked just as well as cognitive behavioral therapy (CBT) to reduce anxiety among cancer survivors. Both approaches led to meaningful and lasting improvements, not only in anxiety, but also in sleep, fatigue and overall quality of life. These findings give patients more flexible, evidence-based options for managing emotional health after cancer. (posted 6/12/2026)
READ MORE ›
Relevance: Medium-High
Most relevant for: People with a BRCA1 or BRCA2 mutation who have had ovarian cancer
Study: Breast cancer risk after ovarian cancer in women with BRCA mutations
Women who have an inherited mutation in BRCA1 or BRCA2 have a higher lifetime risk of developing breast and ovarian cancer compared to women without these mutations. This study found that after being diagnosed with ovarian cancer, women with a BRCA1 or BRCA2 mutation have a relatively low risk of developing breast cancer. (posted 5/18/2026)
READ MORE ›
Relevance: Medium
Most relevant for: Women with menopause symptoms currently using or considering hormone therapy
Update: Hormone therapy for menopause
For people living with menopause symptoms like hot flashes, night sweats, joint pain or vaginal dryness, menopausal hormone therapy may be a helpful option to address these symptoms. This includes people at high risk for ovarian cancer who experience early menopause after risk-reducing surgery. The FDA recently updated its guidance to remove some of the strongest warning labels from these treatments. This change could make it easier for you and your doctor to decide if hormone therapy is right for you. (posted 4/27/2026)
READ MORE ›
Relevance: High
Most relevant for: People with a PALB2 mutation
Study: Understanding inherited PALB2 mutations and risk of multiple cancers
Inherited mutations in the PALB2 gene are linked to increased risk of several cancers, including breast, pancreatic, ovarian, and prostate cancers. This study estimates the effect of an inherited PALB2 mutation on a person’s risk of developing each of these cancers. (posted 4/6/2026)
READ MORE ›
Relevance: High
Most relevant for: People who are experiencing pelvic side effects related to treatment or surgery
Article: Pelvic health therapy improves quality of life after treatment or prevention
Pelvic health therapy can significantly improve comfort, function and quality of life for people experiencing pelvic pain, bladder or bowel issues, and sexual dysfunction after cancer treatment or preventive surgery. This article highlights the importance of restoring tissue mobility, strengthening the pelvic floor and providing emotional support to empower survivors and previvors. (posted 3/23/2026)
READ MORE ›